TD Cowen’s $30.3 target on RXO

RXO Rxo Inc

$28.6 → $30.3 (+6%) by Oct 2027

Hold · raises · said Oct 6, 2026 · 12-month default horizon

Open: judged on the close on Oct 6, 2027

The article this target came from

TD Cowen upgrades RXO stock rating to hold on acquisition news

Investing.com · Oct 6, 2026

TD Cowen upgraded RXO, Inc. (NYSE:RXO) from Sell to Hold and raised its price target to $30.25 from $17.50.

TD Cowen’s track record → Rxo Inc →

A fact about what TD Cowen published, as reported by Investing.com, not a recommendation from Dalsna Finance; TD Cowen is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.